Searchable abstracts of presentations at key conferences in endocrinology

ea0044ep52 | (1) | SFEBES2016

Adrenal carcinoma, a rare incidental finding: case presentation

Hilma Ana Maria , Gogoi Adriana , Jercalau Simona , Badiu Corin

Adrenal carcinoma is a very rare malignancy accounting for 0.05–0.2% of all cancers, with an incidence 0.5–2/106.We present the case of a 60 year old woman with impaired fasting glucose and hypertension, who was incidentally diagnosed, after a non-enhanced abdominal CT, with a right adrenal tumor of 4.5/6 cm. The mass was described as having smooth borders, and a heterogeneous aspect including solid parts, necrotic areas and 1 microc...

ea0041gp185 | Reproduction & Endocrine Disruption | ECE2016

Human Chorionic Gonadotropin supports Treg-mediated fetal protection in mice by modulating DC phenotype

Schumacher Anne , Sporke Dominique , Ehrentraut Stefanie , Claudia Zenclussen Ana

Introduction: Human Chorionic Gonadotropin (hCG) contributes to fetal tolerance by regulating innate and adaptive immune responses during pregnancy. Our previous results suggested a pregnancy protective effect of hCG through enhancement of regulatory T (Treg) cells and inhibition of dendritic cell (DC) maturation. Here, we aimed to investigate whether hCG contributes to Treg generation by modulating DC phenotype in vitro and in vivo in a murine model.<p c...

ea0041ep88 | Adrenal medulla | ECE2016

High prevalence of germinal mutations in pheochromocytomas with normal urinary metanephrines results

Silva Joao , Prazeres Susana , Domingues Rita , Font Ana , Leite Valeriano

Introduction: Pheochromocytomas are tumors derived from the adrenal-medullary chromaffin cells that normally produce catecholamines. Rarely these tumors are non-secreting. In the assessment of a suspected pheochromocytoma, guidelines recommend dosing urinary or plasma metanephrines.Objective: To evaluate the prevalence of pheochromocytomas biochemically non-secreting and their differences.Methods: We searched all patients with meas...

ea0041ep616 | Endocrine tumours and neoplasia | ECE2016

Clinical benefit of patients with advanced adrenocortical carcinoma (Acc) treated in phase I clinical trials: the royal marsden hospital (Rmh) experience

Custodio Ana , Lopez Juanita , de Bono Johann S

Introduction: After progression on conventional treatment options, some patients with advanced ACC are offered experimental Phase I therapies. The outcomes of these patients have not yet been formally evaluated. This study aims to describe the experience of refractory ACC patients treated on Phase I clinical trials at the RMH.Methods: We retrospectively reviewed the records of metastatic ACC patients consecutively treated in our Drug Development Unit bet...

ea0041ep722 | Male Reproduction | ECE2016

Hypogonadotropic hypogonadism – clinical spectrum: from sporadic to familiar forms

Saavedra Ana , Rodrigues Elisabete , Lemos Manuel , Carvalho Davide

Introduction: Congenital hypogonadotropic hypogonadism (CHH) is a rare disorder. It can be sporadic or familiar and is divided into anosmic hypogonadotropic hypogonadism (Kallmann syndrome - KS) and congenital normosmic isolated hypogonadotropic hypogonadism (idiopathic hypogonadotropic hypogonadism &hyphen; IHH). A growing number of genes are involved in its etiology, suggesting the heterogeneity and complexity of this condition.Cases Reports: Six cases...

ea0041ep1089 | Thyroid cancer | ECE2016

Malignancy in AUS/FLUS: can we create a predictive score?

Silva Silvia , Rafael Ana , Marques Ricardo , Fernandes Luis

Background: Thyroid AUS/FLUS lesions continue to be a grey area regarding the surgery to be carried out. Our aim was to create a predictive malignancy score to help in surgical decision.Methods: Retrospective study of 2981 patients and 3557 thyroid Fine-needle aspirations (FNAs) between January 2012 to December 2014. Ultrasound and cytological findings considered suspicious by the ATA guidelines were analyzed. Malignant group was compared with a control ...

ea0038oc3.3 | Steroids and adrenal | SFEBES2015

11β-HSD1-mediated decrease in COX2 expression is abrogated by hypoxia in human dermal fibroblasts

Tiganescu Ana , Wittmann Miriam , Morgan Ann , Stewart Paul

Chronic wounds contribute significantly to patient morbidity, mortality and associated healthcare costs. Glucocorticoid (GC) excess and hypoxia are both associated with impaired wound healing (WH) outcomes. The cyclooxygerase 2 (COX2) pathway is an integral component of inflammation and WH. Locally, GC availability is regulated by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) which generates cortisol from inactive cortisone. Although we recently demon...

ea0037ep775 | Pituitary: clinical | ECE2015

Congenital pituitary stalk interruption syndrome with isolated GH and TSH deficiency and Rathke's cleft cyst: an incidental association

Wessling Ana , Paixao Raquel , Aragues Jose Maria , Mascarenhas Mario

Introduction: Congenital pituitary stalk interruption syndrome (PSIS) is a rare condition, characterized by the triad (not always complete): absence/hypoplasia of the pituitary stalk, hypoplasia/aplasia of the anterior pituitary and absence or ectopy of the posterior pituitary high signal intensity, on magnetic resonance imaging (MRI). PSIS implies a permanent GH deficiency, in 77% associated with other pituitary hormones deficiencies. The aetiology remains uncertain, but some...

ea0037ep1306 | Clinical Cases–Thyroid/Other | ECE2015

Takotsubo cardiomyopathy associated with levothyroxine over-replacement

Balsa Ana Margarida , Ferreira Raquel , Dantas Rosa , Guimaraes Joana

Background: Takotsubo cardiomyopathy (TC) is characterised by acute, transient left ventricular apical ballooning precipitated by emotional or physiologically stressful stimuli and has been previously associated with Graves’ disease based on few clinical reports. More recently, the association with exogenous thyrotoxicosis and radioiodine-induced thyroiditis has also been described. Iatrogenic hyperthyroidism on patients under levothyroxine replacement therapy for hypothy...

ea0035p350 | Diabetes (epidemiology, pathophysiology) | ECE2014

Clinical case of type 1 diabetes mellitus and multiple sclerosis – just bad luck?

Wessling Ana , Aragues Jose Maria , Guerra Silvia , Mascarenhas Mario

Introduction: Type 1 diabetes mellitus (T1DM) and multiple sclerosis (MS) are organ-specific autoimmune diseases. Their association, first described in a study in Sardinia, left questions about their clustering, clarified by the Familial Autoimmune and Diabetes Study, which showed for the first time an highly increased prevalence of MS in adults with T1DM, reinforced by further epidemiological studies that also revealed increased risk of T1DM in MS patients.<p class="abste...